Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more

[04-05-2021 04:25 PM]

Ammon News - CVS Health (CVS) – The drug store and pharmacy benefits management company earned $2.04 per share in the first quarter, above the consensus estimate of $1.72 a share. Revenue also came in above Wall Street forecasts. CVS saw higher sales at its stores, with customer traffic spurred by Covid-19 vaccination visits. CVS also raised its full-year forecast, and its shares rose 3% in the premarket, cnbc reported.

iRobot (IRBT) – iRobot earned 41 cents per share during the first quarter, compared to a consensus estimate of 9 cents a share. The maker of the Roomba robotic vacuum’s revenue exceeded estimates as well, however the stock tumbled 8.6% in the premarket on concerns about shipping and component costs, according to cnbc.

Pfizer (PFE) – The drugmaker beat estimates by 16 cents a share, with quarterly profit of 93 cents per share. Revenue also came in above forecasts and the company raised its full-year guidance as sales of its Covid-19 vaccine continue to be stronger than expected. Additionally, the Food and Drug Administration is set to authorize the vaccine for use in adolescents aged 12-15, according to federal officials familiar with the plan who spoke to The New York Times. Pfizer shares added 1.3% in premarket trading.

Vaxart (VXRT) – Vaxart surged 18.6% in premarket trading after it reported positive results in a phase 1 trial of its oral Covid-19 vaccine. Vaxart said the vaccine could be just as effective as the injected vaccines developed by Pfizer and Moderna (MRNA).

Under Armour (UAA) – The athletic apparel maker’s stock climbed 2.8% in premarket action after it reported first-quarter profit of 16 cents per share, well above the 3 cents a share consensus estimate. Revenue also topped analysts’ forecasts and Under Armour raised its full-year outlook as reopening markets spur demand for shoes and apparel. Separately, the company agreed to pay $9 million to settle a Securities and Exchange Commission probe into its accounting.

DuPont (DD) – The industrial materials maker reported quarterly profit of 91 cents per share, 15 cents a share above estimates. Revenue also topped analysts’ forecasts. DuPont is seeing strong demand for its products from semiconductor makers as well as automobile markets, and the company raised its full-year profit and revenue forecast.

XPO Logistics (XPO) – XPO reported quarterly earnings of $1.46 per share, well above the consensus estimate of 97 cents a share. The transportation company’s revenue was also above Wall Street forecasts, reaching record levels in sharp contrast to usual seasonal trends. XPO also raised its full-year forecast, but its shares lost 1.2% in premarket action.

Avis Budget (CAR) – Avis Budget lost 46 cents per share for the first quarter, smaller than the loss of $2.16 a share predicted by analysts. The car rental company’s revenue beat Wall Street forecasts as well amid a jump in demand and more solid pricing for car rentals. The stock fell 1.4% in premarket action despite the upbeat results.

Qiagen (QGEN) – Qiagen reported better-than-expected earnings and sales for its latest quarter, as the genetic testing company saw increasing demand for non-coronavirus products as well as strength in its Covid-19 testing business.

SmileDirectClub (SDC) – SmileDirectClub said its current-quarter sales will be hurt by an April cyberattack, costing it between $10 million and $15 million. The maker of teeth-straightening systems said it successfully blocked the attack and restored its systems to normal. The stock lost 9.2% in the premarket. (Disclosure: NBC Nightly News investigated SmileDirectClub’s customer complaints in February. The company accused NBCUniversal of publishing false information about the company and is seeking $2.85 billion for defamation.)

Domtar (UFS) – Domtar shares soared 16.1% in premarket action following a Bloomberg report that said Canada’s Paper Excellence is exploring a deal to buy its U.S.-based paper and packaging rival. A deal could value Domtar in the mid-$50 per share range, compared to Monday’s close of $40.52 a share.

  • no comments

All comments are reviewed and posted only if approved.
Ammon News reserves the right to delete any comment at any time, and for any reason, and will not publish any comment containing offense or deviating from the subject at hand, or to include the names of any personalities or to stir up sectarian, sectarian or racial strife, hoping to adhere to a high level of the comments as they express The extent of the progress and culture of Ammon News' visitors, noting that the comments are expressed only by the owners.
name : *
show email
comment : *
Verification code : Refresh
write code :